课题基金 / 基金详情

项目摘要

项目成果

Mark A Marzinke的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The overall goal of the Analytical, Biostatistical and Pharmaceutics Core (Analytical Core C) is to provide support to the DREAM Program with respect to rectal microbicide enema formulation and physical characterization for tenofovir (TFV) and TFV prodrugs (TFV disoproxil fumarate [TDF], TFV alafenamide fumarate [TAF], and CMX157), development and application of quantitative methods for biological sample analysis, and statistical analysis of study data. The operations of Core C focus around the central idea of analysis, with regards to pharmaceutical product formulation (pharmaceutics), drug concentration in biological matrices (analytical), and statistical interpretation of generated data (biostatistical). For bioanalytical studies, Analytical Core C will focus on the development and validation of liquid chromatographic-tandem mass spectrometric (LC-MS/MS) methods for the quantification of TFV and TFV prodrugs in plasma, rectal fluid, and tissue. Biopharmaceutical work conducted in Analytical Core C will focus on the development of extemporaneous compounding methods and quality assessments for TFV enema products. The Biostatistical expertise within Analytical Core C will allow the DREAM program to use statistical algorithms to project TFV and TFV prodrug kinetics in the colon. Thus, each area within Analytical Core C will work in tandem to support the pre-clinical and clinical projects of the DREAM program. Analytical Core C has significant experience in the areas of bioanalysis, formulation development, and biostatistical image analysis. Further, Drs. Marzinke (Analytical Core C Leader), Rohan (Analytical Core C Co-Leader) and Caffo have long-standing collaborations with Dr. Craig Hendrix, the principal investigator of the DREAM program. Through the provision of pharmacokinetic data on TDF, TAF, and CMX157, the core will directly support Projects 1, 2 and 3 of this grant proposal. Formulation based efforts provided through this Core will assist Projects 1, 2, 3, & 4 as well as Core B.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Improving PrEP protection of transgender women through mechanistic pharmacokinetic understanding
  • 批准号:
    10355444
  • 项目类别:
  • 资助金额:
    $56.76万
  • 财政年份:
    2019
  • 负责人:
    Mark A Marzinke
  • 依托单位:
Improving PrEP protection of transgender women through mechanistic pharmacokinetic understanding
  • 批准号:
    9891005
  • 项目类别:
  • 资助金额:
    $56.76万
  • 财政年份:
    2019
  • 负责人:
    Mark A Marzinke
  • 依托单位:
Bioanalytical and Formulation Core
  • 批准号:
    8768694
  • 项目类别:
  • 资助金额:
    $44.94万
  • 财政年份:
    2014
  • 负责人:
    Mark A Marzinke
  • 依托单位:
Bioanalytical and Formulation Core
  • 批准号:
    9313777
  • 项目类别:
  • 资助金额:
    $114.8万
  • 财政年份:
    --
  • 负责人:
    Mark A Marzinke
  • 依托单位:
海外基金